Study examining the effect of different diuretics on fluid retention in diabetics treated with rosiglitazone.
A randomised, open-label, parallel group study to evaluate the management of rosiglitazone-related fluid retention by investigating the effect of diuretics on plasma volume in subjects with type 2 diabetes mellitus treated for twelve weeks with rosiglitazone 4mg bd in addition to background anti-diabetic agents.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Enrollment
388
Changes in Haematocrit following 7 days diuretic adminstration.
Total body fluid & extracellular fluid, body weight, haematocrit & haemoglobin.
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
GSK Investigational Site
Brussels, Belgium
GSK Investigational Site
Sint-Gillis-Waas, Belgium
GSK Investigational Site
Winnipeg, Manitoba, Canada
GSK Investigational Site
Aarhus, Denmark
GSK Investigational Site
Hellerup, Denmark
GSK Investigational Site
Hvidovre, Denmark
GSK Investigational Site
Dommartin-lès-Toul, France
GSK Investigational Site
Paris, France
GSK Investigational Site
Heidelberg, Baden-Wurttemberg, Germany
GSK Investigational Site
Munich, Bavaria, Germany
...and 36 more locations